Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention

Authors
Citation
Fg. Hayden, Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention, VACCINE, 19, 2000, pp. S66-S70
Citations number
21
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
19
Year of publication
2000
Supplement
1
Pages
S66 - S70
Database
ISI
SICI code
0264-410X(200012)19:<S66:IVAROM>2.0.ZU;2-X
Abstract
Adults frequently develop eustachian tube dysfunction and middle ear pressu re (MEP) abnormalities during natural and experimental influenza and human rhinovirus (HRV) infections. Oral rimantadine treatment did not reduce the otologic manifestations of experimental influenza in adults or natural infl uenza in children. However, intranasal zanamivir and oral oseltamivir signi ficantly reduced MEP abnormalities during experimental influenza in adults, and oseltamivir treatment appears to reduce the likelihood of otitis media in children with acute influenza. Investigational anti-HRV agents, includi ng intranasal tremacamra, intranasal AG7088, and oral pleconaril, warrant s tudy in this regard. Depending on the virus, early antiviral therapy has th e potential to impact the risk of otitis media following respiratory tract infections. (C) 2000 Elsevier Science Ltd. All rights reserved.